Nextgen Bioscience is developing treatments for a range of autoimmune and fibrotic diseases, including Alopecia Areata (AA), Ulcerative Colitis (UC), Idiopathic Pulmonary Fibrosis (IPF), and Wet Age-Related Macular Degeneration (wet-AMD).
